Massive global study aims to uncover why young cancer patients in poorer nations fare worse

NCT ID NCT07632014

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 6,000 children, adolescents, and young adults with cancer in low- and middle-income countries. Researchers will collect data from medical records and questionnaires to understand why treatment failure and severe side effects are more common in these settings. The goal is to identify barriers to care and inform future efforts to improve cancer outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could provide crucial data to help improve cancer care and survival rates for young people in low- and middle-income countries.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. It may also face challenges in data collection across many sites.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Children's Cancer Hospital Egypt 57357

    RECRUITING

    Cairo, 11441, Egypt

  • Unidad Nacional de Oncología Pediátrica (UNOP)

    RECRUITING

    Guatemala City, Guatemala

  • Yeolyan Center for Cancer and Blood Disorders

    RECRUITING

    Yerevan, Armenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.